CHONGKUNDANG HOLDINGS CORP.
Holding company for a group in pharmaceuticals, biotech, and healthcare.
001630 | KO
Overview
Corporate Details
- ISIN(s):
- KR7001630003
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서대문구 충정로 8 종근당빌딩, 서울특별시
- Website:
- https://www.ckd-holdings.com
- Industry:
- Activities of head offices
Description
Chongkundang Holdings Corp. is the holding company for the Chong Kun Dang Group, a comprehensive life care and pharmaceutical conglomerate. The company manages a diverse business portfolio through its principal subsidiaries. Chong Kun Dang Pharmaceutical develops and markets prescription drugs, over-the-counter medications, and specialized treatments. Kyongbo Pharmaceutical manufactures active pharmaceutical ingredients (APIs) and generic drugs. Chong Kun Dang Bio specializes in fermentation technology and biotechnology products, while Chong Kun Dang Health offers a wide range of health functional foods and supplements. Collectively, the group focuses on improving quality of life through innovation in pharmaceuticals, biotechnology, and healthcare solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-12-19 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 82.7 KB | ||
| 2022-12-08 00:00 |
주요사항보고서(무상증자결정)(자회사의 주요경영사항)
|
Korean | 9.6 KB | ||
| 2022-11-22 00:00 |
투자판단관련주요경영사항(자회사의 주요경영사항)
|
Korean | 16.1 KB | ||
| 2022-11-15 00:00 |
신탁계약에의한취득상황보고서
|
Korean | 31.7 KB | ||
| 2022-11-14 00:00 |
분기보고서 (2022.09)
|
Korean | 2.1 MB | ||
| 2022-10-31 00:00 |
투자판단관련주요경영사항(자회사의 주요경영사항)(듀비에에스정(CKD-396) 식품의약품 안전처 국내 품목허가 신청)
|
Korean | 10.3 KB | ||
| 2022-10-25 00:00 |
단일판매ㆍ공급계약체결(자회사의 주요경영사항)
|
Korean | 8.5 KB | ||
| 2022-10-20 00:00 |
투자판단관련주요경영사항(자회사의 주요경영사항)(루센비에스주(루센티스 바이오시밀러) 식품의약품안전처 국내 품목허가 승인)
|
Korean | 10.0 KB | ||
| 2022-10-19 00:00 |
신탁계약해지결과보고서
|
Korean | 23.1 KB | ||
| 2022-10-14 00:00 |
주요사항보고서(자기주식취득신탁계약해지결정)
|
Korean | 25.4 KB | ||
| 2022-10-13 00:00 |
주요사항보고서(자기주식취득신탁계약체결결정)(자회사의 주요경영사항)
|
Korean | 24.6 KB | ||
| 2022-10-13 00:00 |
주요사항보고서(자기주식취득신탁계약해지결정)(자회사의 주요경영사항)
|
Korean | 22.8 KB | ||
| 2022-09-23 00:00 |
투자판단관련주요경영사항(자회사의 주요경영사항)(듀비메트에스서방정(CKD-393) 식약처 허가신청)
|
Korean | 11.1 KB | ||
| 2022-08-16 00:00 |
반기보고서 (2022.06)
|
Korean | 2.1 MB | ||
| 2022-08-12 00:00 |
주요사항보고서(자기주식취득신탁계약체결결정)
|
Korean | 28.0 KB |
Automate Your Workflow. Get a real-time feed of all CHONGKUNDANG HOLDINGS CORP. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CHONGKUNDANG HOLDINGS CORP.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CHONGKUNDANG HOLDINGS CORP. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
